Table 2.
Status | HIV-negative | Asymptomatic | At cART initiation | Upon cART initiation | ||
---|---|---|---|---|---|---|
Vaccine efficacy Low → High | ||||||
Goal | Prevention of infection | Block of progression (no cART need) | Faster and more efficient response to therapy | cART intensification | cART simplification | cART interruption |
(functional cure, eradication) | ||||||
Primary (short-term) end-points | HIV test Viral load CD4 counts |
CD4 counts Viral load Time to cART initiation |
CD4 counts Viral load Time to infection control |
CD4 counts Viral load |
||
Secondary (long-term) end-points | None | Proviral DNA (Integrated, non-integrated, total) Neutralization of Tat/Env entry in DCs Markers of immune activation and reconstitution |